-
RELATION NAME
-
[2] Azzopardi N., Fenech M., Piscopo T., Sepsis, the Liver and the Gut, Sepsis–An Ongoing and Significant Challenge, InTech, 2012
-
RELATION NAME
-
[4] Mammen J.M.V.M., Matthews J.B.M., Mucosal repair in the gastrointestinal tract, Critical Care Medicine Healing Responses in Critical Illness, 2003,31,S532-S537
-
[5] Thim L., A new family of growth factor-like peptides: ‘trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP) and frog skin peptides (spasmolysins), FEBS Lett., 1989, 250, 85-90
-
[6] Hauser F., Poulsom R., Chinery R., Rogers L.A., Hanby A.M., Wright N.A., et al., hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus, Proc. Natl. Acad. Sci. USA, 1993, 90, 6961-6965
-
[7] Xian C.J., Howarth G.S., Mardell C.E., Cool J.C., Familari M., Read L.C., et al., Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair, Am J Physiol, 1999,277, G785-G795
-
[8] Babyatsky M.W., deBeaumont M., Thim L., Podolsky D.K., Oral trefoil peptides protect against ethanol- and indomethacininduced gastric injury in rats, Gastroenterology, 1996,110, 489-497
-
[9] Schwarzberg H., Kalbacher H., Hoffmann W., Differential behavioral effects of TFF peptides: Injections of synthetic TFF3 into the ratamygdala, Pharmacol BiochemBehav, 1999,62,173-178
-
RELATION NAME